Categories Earnings, Health Care

Earnings Summary: Highlights of CooperCompanies’ (COO) Q4 2023 financial results

Medical device maker CooperCompanies (NYSE: COO) announced financial results for the fourth quarter of 2023, reporting an increase in revenues and adjusted profit.

  • Fourth quarter revenue came in at $927.1 million, which is up 9% year-over-year. Revenue grew 9% organically
  • Q4 net income increased to $84.5 million from $65.6 million in the corresponding period of 2022
  • Earnings, on a per-share basis, was $1.70 in the October quarter, higher by 29% compared to last year
  • Adjusted earnings per share, excluding special items, increased 26% annually to $3.47 in Q4
  • Adjusted gross margin rose to 67% from 65% last year driven by better operational performance at both CooperVision and CooperSurgical, and favorable currency
  • The company ended the quarter with an operating cash flow of 174.2 million; offset by capital expenditures of $145.0 million, the free cash flow was $29.2 million

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

QCOM Earnings: Qualcomm Q2 2024 revenue and profit beat Street view

Semiconductor company Qualcomm, Inc. (NASDAQ: QCOM) reported an increase in earnings and revenues for the second quarter of 2024. The numbers came in above analysts' estimates. At $9.39 billion, March-quarter

Key takeaways from Amazon’s Q1 2024 earnings report

Amazon.com Inc. (NASDAQ: AMZN) had an upbeat start to fiscal 2024, delivering strong growth across the business in the first three months of the year. While the cloud segment continues

Key takeaways from Pfizer’s (PFE) Q1 2024 earnings report

Shares of Pfizer Inc. (NYSE: PFE) gained over 5% on Wednesday following the company’s announcement of its first quarter 2024 earnings results. Although the top and bottom line numbers decreased

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top